Published in Shock on August 01, 1997
Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis. BMC Emerg Med (2008) 1.25
Pro/con clinical debate: do colloids have advantages over crystalloids in paediatric sepsis? Crit Care (2002) 0.83
Effects of synthetic colloid and crystalloid solutions on hemorheology in vitro and in hemorrhagic shock. Eur J Med Res (2015) 0.75
Pro/con debate: should synthetic colloids be used in patients with septic shock? Crit Care (2009) 0.75
Effect of crystalloid and colloid solutions on blood rheology in sepsis. Victor J. Castro, Mark E. Astiz, and Eric C. Rackow. Shock 8:104-107, 1997. Shock (1998) 0.75
Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med (2000) 3.00
End-tidal carbon dioxide concentration during cardiopulmonary resuscitation. N Engl J Med (1988) 2.80
Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med (1983) 2.36
Decreases in mortality on a large urban medical service by facilitating access to critical care. An alternative to rationing. Arch Intern Med (1988) 1.86
Venous hypercarbia associated with severe sepsis and systemic hypoperfusion. Crit Care Med (1990) 1.74
Cardiac output and end-tidal carbon dioxide. Crit Care Med (1985) 1.71
Difference in acid-base state between venous and arterial blood during cardiopulmonary resuscitation. N Engl J Med (1986) 1.66
Relationship of oxygen delivery and mixed venous oxygenation to lactic acidosis in patients with sepsis and acute myocardial infarction. Crit Care Med (1988) 1.58
Expired carbon dioxide: a noninvasive monitor of cardiopulmonary resuscitation. Circulation (1988) 1.50
Alterations in C3, C4, factor B, and related metabolites in septic shock. Clin Immunol Immunopathol (1993) 1.44
Increased venous-arterial carbon dioxide tension difference during severe sepsis in rats. Crit Care Med (1994) 1.44
Unaccounted for anion in metabolic acidosis during severe sepsis in humans. Crit Care Med (1991) 1.40
Competent and continuing care of the critically ill. Crit Care Med (1988) 1.39
Monophosphoryl lipid A attenuates the effects of endotoxic shock in pigs. J Lab Clin Med (1992) 1.38
The first decade of the American Board of Internal Medicine certification in critical care medicine: an overview of examinees and certificate holders from 1987 through 1996. Crit Care Med (2000) 1.38
Septic shock. Lancet (1998) 1.26
Arteriovenous carbon dioxide and pH gradients during cardiac arrest. Circulation (1986) 1.24
Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock. Crit Care Med (2001) 1.19
Acute pulmonary edema in Plasmodium falciparum malaria. Am Rev Respir Dis (1978) 1.19
Decreased response to recall antigens is associated with depressed costimulatory receptor expression in septic critically ill patients. J Lab Clin Med (2000) 1.15
Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock. Crit Care Med (1983) 1.14
Arterial PCO2 as an indicator of systemic perfusion during cardiopulmonary resuscitation. Crit Care Med (1989) 1.13
Comparison of blood lactate concentrations in central venous, pulmonary artery, and arterial blood. Crit Care Med (1987) 1.12
Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD11b, CD14, and IL-2R expression. Chest (1993) 1.12
End-tidal CO2 as a guide to successful cardiopulmonary resuscitation: a preliminary report. Crit Care Med (1985) 1.11
Buffer agents do not reverse intramyocardial acidosis during cardiac resuscitation. Circulation (1990) 1.10
Triage considerations in medical intensive care. Arch Intern Med (1990) 1.07
Microvascular function and rheologic changes in hyperdynamic sepsis. Crit Care Med (1995) 1.06
Cardiopulmonary resuscitation in the rat. J Appl Physiol (1985) (1988) 1.06
Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial. Crit Care Med (1995) 1.03
Pathophysiology and treatment of septic shock. JAMA (1991) 1.01
Effects of hetastarch and albumin on coagulation in patients with septic shock. J Clin Pharmacol (1988) 1.01
Oxygen delivery and consumption in patients with hyperdynamic septic shock. Crit Care Med (1987) 1.00
The relationship of the colloid osmotic-pulmonary artery wedge pressure gradient to pulmonary edema and mortality in critically ill patients. Chest (1982) 0.99
Relationships between plasma cytokine concentrations and leukocyte functional antigen expression in patients with sepsis. Crit Care Med (1994) 0.98
Unmeasured anion during severe sepsis with metabolic acidosis. Circ Shock (1990) 0.96
Myocardial acidosis associated with CO2 production during cardiac arrest and resuscitation. Circulation (1989) 0.96
Prolongation of the half-life of lactate after maximal exercise in patients with hepatic dysfunction. Crit Care Med (1989) 0.94
Microvascular response in patients with cardiogenic shock. Crit Care Med (2000) 0.94
'Lactate washout' following circulatory arrest. JAMA (1988) 0.94
The spectrum of pulmonary edema: differentiation of cardiogenic, intermediate, and noncardiogenic forms of pulmonary edema. Am Rev Respir Dis (1981) 0.94
Pulmonary edema; a complication of diabetic ketoacidosis. Chest (1980) 0.93
Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Crit Care Med (1982) 0.93
Neurogenic pulmonary edema. Chest (1982) 0.91
Early impairment of oxidative metabolism and energy production in severe sepsis. Circ Shock (1988) 0.91
Intramyocardial hypercarbic acidosis during cardiac arrest and resuscitation. Crit Care Med (1993) 0.91
Non-ICU care of hemodynamically stable mechanically ventilated patients. Chest (1996) 0.90
Improved survival in patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure. Chest (1989) 0.90
Monophosphoryl lipid A protects against gram-positive sepsis and tumor necrosis factor. Shock (1994) 0.89
Sublingual capnometry and indexes of tissue perfusion in patients with circulatory failure. Chest (2001) 0.89
Colloid osmotic pressure as a prognostic indicator of pulmonary edema and mortality in the critically ill. Chest (1977) 0.88
The relationship between oxygen delivery and consumption during fluid resuscitation of hypovolemic and septic shock. Chest (1984) 0.88
Uremic pulmonary edema. Am J Med (1978) 0.87
Influence of rheologic changes and platelet-neutrophil interactions on cell filtration in sepsis. Am J Respir Crit Care Med (2000) 0.86
Adverse effects of febrile state on cardiac performance. Am Heart J (1983) 0.85
Comparison of the induction of endotoxin tolerance in endotoxemia and peritonitis by monophosphoryl lipid A and lipopolysaccharide. Circ Shock (1993) 0.85
Acid-base determinants of survival after cardiopulmonary resuscitation. Crit Care Med (1985) 0.85
Induction of endotoxin tolerance with monophosphoryl lipid A in peritonitis: importance of localized therapy. J Lab Clin Med (1994) 0.84
Reversible impairment of myocardial contractility due to hypercarbic acidosis in the isolated perfused rat heart. Crit Care Med (1991) 0.84
Cardiac effects of carbon dioxide-consuming and carbon dioxide-generating buffers during cardiopulmonary resuscitation. J Am Coll Cardiol (1990) 0.84
Delayed lactate clearance in patients surviving circulatory shock. Acute Care (1985) 0.84
Septic encephalopathy. Evidence for altered phenylalanine metabolism and comparison with hepatic encephalopathy. Arch Intern Med (1990) 0.84
Intravascular volume and fluid therapy for severe sepsis. New Horiz (1993) 0.83
Colloid and crystalloid fluid resuscitation. Acute Care (1985) 0.83
Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion. Crit Care Med (1989) 0.83
Training and certification of critical care medicine in the United States. Chest (1988) 0.83
Cellular oxygen metabolism during sepsis and shock. The relationship of oxygen consumption to oxygen delivery. JAMA (1988) 0.82
Skeletal muscle blood flow and venous capacitance in patients with severe sepsis and systemic hypoperfusion. Chest (1989) 0.82
End tidal carbon dioxide as an haemodynamic determinant of cardiopulmonary resuscitation in the rat. Cardiovasc Res (1989) 0.81
Effects of tromethamine and sodium bicarbonate buffers during cardiac resuscitation. J Clin Pharmacol (1988) 0.81
Effects of crystalloid and colloid fluids on extravascular lung water in hypoproteinemic dogs. J Appl Physiol (1985) (1987) 0.81
Assessing perfusion failure during circulatory shock. Crit Care Clin (1993) 0.80
Monophosphoryl lipid A stimulated up-regulation of reactive oxygen intermediates in human monocytes in vitro. J Leukoc Biol (2001) 0.80
Incomplete global myocardial ischemia during cardiac arrest and resuscitation. Crit Care Med (1988) 0.80
Monophosphoryl lipid A blocks the hemodynamic effects of lethal endotoxemia. J Lab Clin Med (1989) 0.80
Echocardiographic observations during cardiopulmonary resuscitation: a preliminary report. Crit Care Med (1985) 0.80
Effects of proinflammatory cytokines and bacterial toxins on neutrophil rheologic properties. Crit Care Med (1998) 0.79
Hemodynamic response to fluid repletion in patients with septic shock: evidence for early depression of cardiac performance. Circ Shock (1987) 0.79
Increases in coronary vein CO2 during cardiac resuscitation. J Appl Physiol (1985) (1990) 0.79
Monophosphoryl lipid A induces tolerance to the lethal hemodynamic effects of endotoxemia. Circ Shock (1991) 0.78
Inotropic response to digoxin and dopamine in patients with severe sepsis, cardiac failure, and systemic hypoperfusion. Chest (1989) 0.78
Monophosphoryl lipid A stimulated up-regulation of nitric oxide synthase and nitric oxide release by human monocytes in vitro. Immunopharmacology (1997) 0.78
Diphosphoryl lipid A from Rhodopseudomonas sphaeroides induces tolerance to endotoxic shock in the rat. Crit Care Med (1993) 0.78